<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02531711</url>
  </required_header>
  <id_info>
    <org_study_id>14-2321</org_study_id>
    <nct_id>NCT02531711</nct_id>
  </id_info>
  <brief_title>Chronic Lumbosacral Radiculopathy: Impact of an Analgesic Dietary Intervention on Pain &amp; Function</brief_title>
  <acronym>LRPD</acronym>
  <official_title>Chronic Lumbosacral Radiculopathy: Impact of an Analgesic Dietary Intervention on Pain &amp; Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>North American Spine Society (NASS)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this proposed research is to assess the preliminary efficacy of dietary
      interventions that change dietary fats in improving clinical outcomes related to lumbar
      radicular pain. After a two-week baseline, consented participants are randomized to one of
      two diets. Key foods consistent with the diet are provided for 12 weeks along with extensive
      dietary counseling and support from the study-provided materials. Participants are encouraged
      to follow the assigned diet for another 6 weeks without provision of food.

      Participants complete questionnaires at baseline, randomization, and after 6 weeks, 12 weeks,
      and 18 weeks on the diet. They provide blood samples at randomization (2 weeks) and after 12
      and 18 weeks on the diet.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lumbar radiculopathy is a fairly common pain syndrome which may result in chronic, severe
      disability. There are few successful treatment options for patients with persistent
      lumbosacral radicular pain (LRP) that does not respond to conventional approaches. A
      fundamental biologic mechanism of chronic LRP, as well as other chronic pain syndromes, may
      involve failure of inflammation-resolution, an active process driven by lipid mediators
      derived from fatty acids (resolvins, protectins, maresins). The investigators' preliminary
      studies indicate that dietary modifications, specifically increasing some dietary fatty
      acids, while reducing others, result in large, statistically significant and clinically
      relevant improvement in headache frequency, intensity, and other clinical outcomes in
      community dwelling persons with chronic headaches.

      The proposed trial represents a promising approach to treatment of a disabling condition,
      lumbar radiculopathy. The previous headache trial by the investigators' interdisciplinary
      UNC/NIH team demonstrated that specific dietary manipulations can produce marked biochemical
      changes and have a major positive clinical impact. This project promises to enhance the
      generalizability of the investigators' approach by expanding from chronic headaches to
      another common chronic pain condition, and also by using a more cost-effective intervention.
      Because dietary modification is a relatively safe and low-cost health-improvement strategy,
      the long-term outcome of this research may be to empower individuals to take a more active
      role in their own health through dietary changes that reduce dependence on medical
      treatments, while providing significant clinical benefits.

      Baseline Phase. Medical records will be obtained for the participant's history and physical
      examination (performed by referring physician at the Spine Center). The baseline visit will
      consist of review of inclusion/exclusion criteria and the components of the study prior to
      consenting. Those who wish to sign the consents will complete baseline assessment instruments
      that measure lumbosacral radiculopathy characteristics and their impact on quality-of-life.
      Through electronic diaries, participants will provide daily data on pain intensity, duration,
      function, sleep quality, and medication use over a 2-week baseline phase. Participants who
      are compliant with all aspects of data collection, and who experience daily radicular pain,
      will be eligible for study intervention participation.

      Randomization. At the end of the 2-week baseline phase, participants who qualify will be
      randomized (computer-generated variable permuted block) to: 1) the High n-3, Low n-6 Diet
      (Analgesic Diet); or 2) the Control Diet. Blood will be collected for baseline biomarker
      assessment prior to beginning study diets.

      Post Randomization. After randomization, participants will attend an initial, in-depth
      dietary counseling session administered by the registered dietitian. Participants will be
      asked to provide a dietary history and will receive detailed instruction in the specific
      dietary intervention per group assignment. Participants in each group will attend a total of
      3 in-person follow-up sessions with the dietitian, for review of their dietary experiences,
      to receive encouragement, to clarify issues, and to have questions answered. At each visit,
      the dietitian will obtain a dietary history and assessment, provide tailored counseling, and
      record data for evaluation of participant variability in order to guide future sessions.
      Participants will have a visit with the dietitian at randomization, two weeks later, 4 weeks
      after that, and 6 weeks after that (at the end of the intervention). In addition, individuals
      will participate in brief (15-20 minute) check-in telephone calls with the dietitian every
      2-3 weeks. Participants will have contact with the research assistant twice weekly to
      encourage diary completion and to invite adverse event reporting.

      During the 12-week intervention phase (weeks 2-14), participants will be provided with
      essential foods to enable them to follow diet recommendations, including study oils, salad
      dressings, and unprepared protein sources (meat, beans, fish). For the remainder of their
      meals, participants will choose food products consistent with their assigned diet. At the
      conclusion of the post-intervention phase (Week 20, Diet week 18), participants will complete
      on-line questionnaires and provide blood samples. The purpose of this post-intervention phase
      is: 1) to obtain pilot data on the ability of participants to continue to achieve nutrient
      intake targets without counseling and food provision; and 2) to obtain pilot data on the
      post-intervention trajectory of biochemical and clinical outcomes.

      Throughout the 12-week active intervention and the 6-week post-intervention phases,
      participants will have access to detailed intervention materials. Diet education materials
      include the diet guidelines, allowed food list, how to read food labels, grocery shopping
      guides for 9 local grocery stores, dining out guide, 7-day meal plan and 75 recipes with the
      ability for the dietitian to add more.

      Food Supply. Participants will visit the dietitian 3 times during the 12-week active
      intervention to obtain specific food items with targeted nutrient compositions. Food items
      will include: cooking oils, salad dressings, mayonnaise, portable dressing packets,
      unprepared frozen food items, and key ingredients for home preparation of meals and snacks.
      All foods have been specifically selected to ensure that participants meet specific nutrient
      intake targets. Prior nutrient analyses of more than 80 relevant food items was performed as
      part of the investigators' previous dietary intervention study in participants with chronic
      daily headache, by the National Institutes of Health-National Institute on Alcohol Abuse and
      Alcoholism Section of Nutritional Neurosciences (SNN). The SNN has agreed to provide further
      nutrient analysis as needed for the proposed study.

      Assessments. Throughout the 2-week baseline, the 12-week active intervention, and 6-week
      post-intervention phases, all participants will record pain intensity, pain interference,
      medication use, activity, and stress using a daily pain diary accessed by mobile device.

      Blood samples will be collected during three visits at the end of the baseline phase (Week 2,
      Diet week 0) and then at study Weeks 14 and 20 (at the end of the active intervention and at
      the end of the post-intervention period) for nutritional and metabolic biomarker measurement.
      At each sample collection visit (and after 6 weeks on the diet), participants will also
      complete the Oswestry Disability Index (ODI) and NIH PROMIS-29 battery (physical function,
      anxiety, depression, fatigue, sleep disturbance, satisfaction with social role, pain
      interference, pain intensity). Every 6 weeks, participants will also be asked about their use
      of other modalities for pain control, including physical therapy, spinal manipulation,
      epidural corticosteroid injections, acupuncture, and yoga.

      Interventions. All participants will receive: 1) tailored dietitian-administered counseling
      consistent with the group assignment; 2) access to intervention-specific informational
      materials and daily outcome assessments; and 3) critical food items with precisely quantified
      fatty acid composition, selected to meet nutrient intake targets specific for each of the
      assignment groups.

      Random Allocation. At the first intervention visit, At Week 2, the research dietitian will
      enter the participant's assigned ID into an online computer program that will determine
      assignment to one of the two diets. Using a random number sequence to generate a permuted
      block of 2-4, the program ensures equal numbers of participants in each arm. The program
      documents treatment assignment in an un-editable form including a date stamp.

      Masking. The research staff, masked to treatment assignment, will schedule all study-related
      visits in the Clinical and Translational Research Center (CTRC) or other appropriate site in
      the University of North Carolina (UNC) Healthcare system or medical school. Only the
      dietitian will, of necessity, be unmasked. All investigators and laboratory personnel will be
      masked to dietary assignment. Masking will be maintained in the random allocation procedure.
      The research dietitian will not indicate to participants which diets are considered to be
      treatment diets vs. the control diet.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oswestry Disability Index--Primary clinical outcome</measure>
    <time_frame>12 weeks</time_frame>
    <description>Measure of pain-specific quality of life</description>
  </primary_outcome>
  <primary_outcome>
    <measure>17-Hydroxy Docosahexaenoic acid (DHA)--Primary biochemical outcome</measure>
    <time_frame>12 weeks</time_frame>
    <description>Metabolite related to dietary fatty acid intakes implicated in pain reductions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain intensity</measure>
    <time_frame>12 weeks</time_frame>
    <description>Average weekly pain intensity, measured in daily diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity</measure>
    <time_frame>12 weeks</time_frame>
    <description>Average weekly steps per day, measured by pedometer (Fitbit)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep efficiency</measure>
    <time_frame>12 weeks</time_frame>
    <description>Measured by percent of time asleep out of total time in bed (Fitbit)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep quantity</measure>
    <time_frame>12 weeks</time_frame>
    <description>Measured by average weekly hours of sleep (Fitbit)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-reported health</measure>
    <time_frame>12 weeks</time_frame>
    <description>PROMIS-29: includes physical function, social functioning, psychological distress, sleep quality, and fatigue</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Red blood cell fatty acids</measure>
    <time_frame>Measured at Week 2 and after 6 and 12 weeks on the diet</time_frame>
    <description>Measures adherence to dietary recommendations</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Borkovec and Nau scale</measure>
    <time_frame>Measured at Week 2</time_frame>
    <description>Measures credibility and expectation of benefit</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Diet A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dietary intervention: Dietary fats are adjusted. Key study foods and oils are provided for 12 weeks. Participants learn which foods to eat and which to avoid.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diet B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dietary intervention: This diet also adjusts dietary fats, and provides key study foods and oils for 12 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diet A</intervention_name>
    <description>Experimental analgesic dietary intervention</description>
    <arm_group_label>Diet A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diet B</intervention_name>
    <description>Healthy comparator diet</description>
    <arm_group_label>Diet B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        MRI-verified lumbosacral radiculopathy associated with herniated disc, spinal stenosis, or
        post-surgical fibrosis

          -  Pain reaching to the knee for at least 12 weeks

          -  Willing to complete daily diary for 20 weeks, as evidenced by completion of â‰¥12 of the
             first 14 days

          -  Possessing a mobile device (smart phone, tablet, laptop) capable of accessing the
             application and website

          -  Able to attend dietitian counseling sessions in Chapel Hill, NC

          -  Under care of a physician for LR

          -  Able to read and communicate in English

        Exclusion Criteria:

          -  Psychosis or severe depression, anxiety, substance abuse disorder

          -  History of specific food allergies that would prevent adherence to study diet

          -  Aversion to eating fish

          -  Currently taking fish oil or other supplements that contain fatty acids under
             investigation

          -  Pregnancy or anticipated pregnancy

          -  Active treatment for a major medical illness, such as malignancy, autoimmune, immune
             deficiency disorder

          -  History of vasculitis, intracranial mass, clotting disorder (including
             medication-induced, e.g., warfarin)

          -  Cognitive dysfunction preventing informed consent

          -  Pending personal injury litigation, including worker's compensation

          -  Chronic long-term disability related to lumbosacral injury/symptoms
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kevin Carneiro, DO</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Physical Medicine and Rehabilitation, University of North Carolina at Chapel Hill</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chanee Lynch, MPH</last_name>
    <phone>919-966-8586</phone>
    <email>food4relief@med.unc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Keturah R Faurot, PhD</last_name>
    <phone>919-966-8586</phone>
    <email>food4relief@med.unc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of North Carolina at Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599-7200</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chanee E Lynch, MPH</last_name>
      <phone>919-966-8586</phone>
      <email>chanee_lynch@med.unc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kim Faurot, PhD</last_name>
      <phone>919-445-6112</phone>
      <email>faurot@med.unc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Kevin Carneiro, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 8, 2015</study_first_submitted>
  <study_first_submitted_qc>August 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2015</study_first_posted>
  <last_update_submitted>April 20, 2018</last_update_submitted>
  <last_update_submitted_qc>April 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lumbosacral</keyword>
  <keyword>radicular</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Radiculopathy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Deidentified data will be shared with investigators at NIH.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

